The following pages link to Statistics in Medicine (Q57552):
Displaying 50 items.
- The personalised randomized controlled trial: evaluation of a new trial design (Q6617471) (← links)
- The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows (Q6617473) (← links)
- Measuring the performance of prediction models to personalize treatment choice (Q6617477) (← links)
- Two-phase designs with current status data (Q6617479) (← links)
- A flexible class of generalized joint frailty models for the analysis of survival endpoints (Q6617480) (← links)
- Absolute and relative risk estimation in the presence of outcome ascertainment gaps and competing risks (Q6617482) (← links)
- In the praise of Prais-Winsten: an evaluation of methods used to account for autocorrelation in interrupted time series (Q6617484) (← links)
- Structured time-dependent inverse regression (STIR) (Q6617487) (← links)
- New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes (Q6617488) (← links)
- Simulated annealing for balancing covariates (Q6617489) (← links)
- Model misspecification and robust analysis for outcome-dependent sampling designs under generalized linear models (Q6617490) (← links)
- Design and modeling for drug combination experiments with order effects (Q6617491) (← links)
- Multistate models as a framework for estimand specification in clinical trials of complex processes (Q6617493) (← links)
- Conditional concordance-assisted learning under matched case-control design for combining biomarkers for population screening (Q6617495) (← links)
- Feature-specific inference for penalized regression using local false discovery rates (Q6617496) (← links)
- Fast estimation of mixed-effects location-scale regression models (Q6617498) (← links)
- A Bayesian hierarchical model for signal extraction from protein microarrays (Q6617503) (← links)
- A comparison of different methods to adjust survival curves for confounders (Q6617506) (← links)
- Group sequential multi-arm multi-stage trial design with treatment selection (Q6617507) (← links)
- Multivariate functional mixed model with MRI data: an application to Alzheimer's disease (Q6617508) (← links)
- Mining adverse events in large frequency tables with ontology, with an application to the vaccine adverse event reporting system (Q6617509) (← links)
- Impute-then-exclude versus exclude-then-impute: lessons when imputing a variable used both in cohort creation and as an independent variable in the analysis model (Q6617511) (← links)
- Ranking of average treatment effects with generalized random forests for time-to-event outcomes (Q6617512) (← links)
- Multivariate functional data clustering using adaptive density peak detection (Q6617513) (← links)
- An efficient model-free approach to interaction screening for high dimensional data (Q6617514) (← links)
- Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons (Q6617519) (← links)
- Identifying important gene signatures of BMI using network structure-aided nonparametric quantile regression (Q6617521) (← links)
- Comparisons of statistical methods for handling attrition in a follow-up visit with complex survey sampling (Q6617523) (← links)
- Mediation analysis in the presence of continuous exposure measurement error (Q6617524) (← links)
- Simulating and estimating agreement in the presence of multiple raters and covariates (Q6617527) (← links)
- Bayesian estimation and testing in random-effects meta-analysis of rare binary events allowing for flexible group variability (Q6617530) (← links)
- A Bayesian approach to study design and analysis with type I error rate control for response variables of mixed types (Q6617531) (← links)
- A Bayesian (meta-)regression model for treatment effects on the risk difference scale (Q6617533) (← links)
- Flexible template matching for observational study design (Q6617535) (← links)
- Boosting multivariate structured additive distributional regression models (Q6617538) (← links)
- Sample size calculation for randomized trials via inverse probability of response weighting when outcome data are missing at random (Q6617539) (← links)
- Confidence intervals for prevalence estimates from complex surveys with imperfect assays (Q6617540) (← links)
- An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results (Q6618301) (← links)
- Balancing versus modelling in weighted analysis of non-randomised studies with survival outcomes: a simulation study (Q6618303) (← links)
- Structured learning in time-dependent Cox models (Q6618308) (← links)
- Assessing heterogeneity in surrogacy using censored data (Q6618309) (← links)
- Fractional accumulative calibration-free odds (f-aCFO) design for delayed toxicity in phase I clinical trials (Q6618310) (← links)
- Statistical methods for predicting e-cigarette use events based on beat-to-beat interval (BBI) data collected from wearable devices (Q6618311) (← links)
- Modeling intra-individual inter-trial EEG response variability in autism (Q6618320) (← links)
- The effect of number of clusters and magnitude of within-cluster homogeneity in outcomes on the performance of four variance estimators for a marginal multivariable Cox regression model fit to clustered data in the context of observational research (Q6618321) (← links)
- Bridging the gap between two-stage and joint models: the case of tumor growth inhibition and overall survival models (Q6618322) (← links)
- Detecting responsible nodes in differential Bayesian networks (Q6618323) (← links)
- Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi-center clinical trial (Q6618325) (← links)
- Robust analysis of stepped wedge trials using composite likelihood models (Q6618328) (← links)
- A Bayesian method to detect drug-drug interaction using external information for spontaneous reporting system (Q6618330) (← links)
